ID

22193

Description

A Study of Pertuzumab in Combination With Erlotinib (Tarceva) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02507375

Lien

https://clinicaltrials.gov/show/NCT02507375

Mots-clés

Versions (1)
  1. 22/05/2017 22/05/2017 -
Téléchargé le

22 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT02507375

Anglais

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT02507375

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients greater than or equal to 18 years of age
Description

Adult | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
histological confirmation of non-small cell lung cancer (nsclc)
Description

Non-Small Cell Lung Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0007131
locally advanced or metastatic disease
Description

Disease Advanced Local | Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [2]
C0027627
failure of at least one prior regimen of standard chemotherapy for locally advanced or metastatic disease
Description

Disease Advanced Local | Neoplasm Metastasis | Chemotherapy Regimen Quantity failed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [2]
C0027627
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0231175
life expectancy of more than or equal to 12 weeks
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
ecog performance status of 0-2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
baseline lvef of greater than or equal to 50%
Description

Left ventricular ejection fraction

Type de données

boolean

Alias
UMLS CUI [1]
C0428772
a negative pregnancy test one week prior to treatment and willingness to use contraception among women of childbearing potential
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods Willing

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0600109
availability of histological ffpe tumor tissue
Description

Tumor Formalin-fixed paraffin-embedded tissue Availability of

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C2711483
UMLS CUI [1,3]
C0470187
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy, radiotherapy or immunotherapy within 4 weeks of study day -8
Description

Chemotherapy | Therapeutic radiology procedure | Immunotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0021083
prior treatment with any agent which targets growth factors or their receptors
Description

Pharmaceutical Preparations Targeted Therapy Growth Factor | Pharmaceutical Preparations Targeted Therapy Growth Factor Receptors

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2985566
UMLS CUI [1,3]
C0018284
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C2985566
UMLS CUI [2,3]
C0206454
patients who have not recovered from the acute reversible effects of chemotherapy and radiotherapy
Description

Chemotherapy Effects Reversible | Therapeutic radiology procedure Effects Reversible | Recovery Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1280500
UMLS CUI [1,3]
C0205343
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1280500
UMLS CUI [2,3]
C0205343
UMLS CUI [3,1]
C0237820
UMLS CUI [3,2]
C0332197
history of clinically significant cardiovascular disease
Description

Cardiovascular Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
history or evidence of central nervous system metastases
Description

CNS metastases | CNS metastases Evidence of

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0332120
treatment with any investigational drug within 28 days of the start of the study (day-8)
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
prior cumulative doxorubicin dose of more than 360 mg/m2 or the equivalent
Description

Doxorubicin Cumulative Dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2986497
Retour au début de la page

Similar models

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT02507375

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients greater than or equal to 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma
Item
histological confirmation of non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1])
Disease Advanced Local | Neoplasm Metastasis
Item
locally advanced or metastatic disease
boolean
C0012634 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2])
Disease Advanced Local | Neoplasm Metastasis | Chemotherapy Regimen Quantity failed
Item
failure of at least one prior regimen of standard chemotherapy for locally advanced or metastatic disease
boolean
C0012634 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0231175 (UMLS CUI [3,3])
Life Expectancy
Item
life expectancy of more than or equal to 12 weeks
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Left ventricular ejection fraction
Item
baseline lvef of greater than or equal to 50%
boolean
C0428772 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods Willing
Item
a negative pregnancy test one week prior to treatment and willingness to use contraception among women of childbearing potential
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Tumor Formalin-fixed paraffin-embedded tissue Availability of
Item
availability of histological ffpe tumor tissue
boolean
C0027651 (UMLS CUI [1,1])
C2711483 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Therapeutic radiology procedure | Immunotherapy
Item
prior chemotherapy, radiotherapy or immunotherapy within 4 weeks of study day -8
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
Pharmaceutical Preparations Targeted Therapy Growth Factor | Pharmaceutical Preparations Targeted Therapy Growth Factor Receptors
Item
prior treatment with any agent which targets growth factors or their receptors
boolean
C0013227 (UMLS CUI [1,1])
C2985566 (UMLS CUI [1,2])
C0018284 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C0206454 (UMLS CUI [2,3])
Chemotherapy Effects Reversible | Therapeutic radiology procedure Effects Reversible | Recovery Absent
Item
patients who have not recovered from the acute reversible effects of chemotherapy and radiotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1280500 (UMLS CUI [1,2])
C0205343 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C1280500 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
C0237820 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Cardiovascular Disease
Item
history of clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
CNS metastases | CNS metastases Evidence of
Item
history or evidence of central nervous system metastases
boolean
C0686377 (UMLS CUI [1])
C0686377 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Investigational New Drugs
Item
treatment with any investigational drug within 28 days of the start of the study (day-8)
boolean
C0013230 (UMLS CUI [1])
Doxorubicin Cumulative Dose
Item
prior cumulative doxorubicin dose of more than 360 mg/m2 or the equivalent
boolean
C0013089 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial